ISDA

Entry Detail

PDB ID:

4MF1

Keywords:

Title:

ITK kinase domain in complex with benzothiazole inhibitor 12b (1S,2S)-2-{4-[(DIMETHYLAMINO)METHYL]PHENYL}-N-[6-(1H-PYRAZOL-4-YL)-1,3-BENZOTHIAZOL-2-YL]CYCLOPROPANECARBOXAMIDE

Biological Source:

Source Organism:

Homo sapiens

Host Organism:

Spodoptera frugiperda

PDB Version:

Deposition Date:

2013-08-27

Release Date:

2013-11-13

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.11 Å

R-Value Free:

0.22

R-Value Work:

0.17

R-Value Observed:

0.17

Space Group:

P 1

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:Tyrosine-protein kinase ITK/TSK
Mutations:C477S, E614A, E617A
Chain IDs:A, B
Chain Length:266
Number of Molecules:2
Biological Source:Homo sapiens

UniProt ID:Q08881 Pfam ID:PF07714 EC:2.7.10.2

Ligand Molecules

29Y

Primary Citation

Structure-based design and synthesis of potent benzothiazole inhibitors of interleukin-2 inducible T cell kinase (ITK).

Mackinnon, C.H, Lau, K, Burch, J.D, Chen, Y, Dines, J, Ding, X, Eigenbrot, C, Heifetz, A, Jaochico, A, Johnson, A, Kraemer, J, Kruger, S, Krulle, T.M, Liimatta, M, Ly, J, Maghames, R, Montalbetti, C.A, Ortwine, D.F, Perez-Fuertes, Y, Shia, S, Stein, D.B, Trani, G, Vaidya, D.G, Wang, X, Bromidge, S.M, Wu, L.C, Pei, Z.Show

Bioorg.Med.Chem.Lett. 23 6331 6335 (2013)

PMID: 24138940 DOI: 10.1016/j.bmcl.2013.09.069

Abstact

Inhibition of the non-receptor tyrosine kinase ITK, a component of the T-cell receptor signalling cascade, may represent a novel treatment for allergic asthma. Here we report the structure-based optimization of a series of benzothiazole amides that demonstrate sub-nanomolar inhibitory potency against ITK with good cellular activity and kinase selectivity. We also elucidate the binding mode of these inhibitors by solving the X-ray crystal structures of several inhibitor-ITK complexes.

Legend

Protein

Chemical

Disease

Primary Citation of related structures